Skip to main content
Premium Trial:

Request an Annual Quote

Oxford Gene Technology Receives ISO17025 Accreditation

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Oxford Gene Technology announced this week that it has received ISO/IEC 17025:2005 accreditation for its Genefficiency and CytoSure array comparative genomic hybridization services.

Accreditation was given by the United Kingdom Accreditation Service.

Genefficiency is a high-throughput genomics service that relies on high density, high sensitivity microarrays. CytoSure is for the detection of chromosomal abnormalities and is provided under an agreement with Agilent Technologies.

The ISO 17025 standard relates to laboratory testing, including staff competency, validity and traceability of results, and proficiency in testing using standard and laboratory-developed methods, OGT said. Accreditation followed a detailed external audit by the UK Accreditation Service covering sample tracking and processing, data analysis, quality control, traceability, business continuity, staff training, and general quality and security policies, the Oxford, UK-based firm said.

The company's Genefficiency and CytoSure services received ISO 9001 and ISO 27001 certifications last summer.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.